Moderna said on Monday it has partnered with the ​Coalition for Epidemic Preparedness Innovations ‌to develop a potential vaccine against Bundibugyo ebolavirus, the strain linked to the ongoing ​Ebola outbreak in eastern Democratic ​Republic of Congo.